Please assess the completion status of the following clinical trial:

Trial Title: Effects of Atorvastatin on Endothelial Progenitor Cells After Coronary Surgery

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Patients undergoing elective isolated coronary artery bypass surgery with on-pump technique~* Written informed consent~Exclusion Criteria:~* Concomitant valve or aortic surgery~* Left ventricular aneurysm repair~* Re-operation~* Emergency surgery~* History of myocardial infarction within less than 4 weeks~* Hepatic impairment~* Chronic renal impairment~* Drug related side effects (allergy or hypersensitivity)~* Familial Hyperlipidemia~* Autoimmune conditions which require steroids

- Gender: ALL
- Minimum Age: 30 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Study Arms:
- Atorvastatin (Type: ACTIVE_COMPARATOR): Hydroxymethylglutaryl-CoA Reductase Inhibitors
- Placebo (Type: PLACEBO_COMPARATOR): Atorvastatin like pill

Based on this trial design, predict the completion outcome and termination type (if applicable).